The Prestige LP™ cervical disc is an articulating artificial cervical disc for use in one- or two-level disc replacement procedures.
Features
Meet the Prestige LP™ cervical disc.
Discover features and benefits of the Prestige LP™ cervical disc:
- Proprietary titanium ceramic composite material contains no nickel, cobalt, or chromium
- Titanium ceramic composite for a lower steady state wear-rate of combined motion than stainless steel in combined motion testing1
- 10-year clinical study data for one-and two-level IDE trials2
- Consolidated instrument configuration for improved cost and efficiency†
Implant material demonstrating lower state of wear
- Titanium ceramic composite material (TiC) contains zero nickel, cobalt, or chromium
- TiC metal ion study,3 performed as part of U.S. Investigational Device Exemption (IDE) clinical trials
- TiC demonstrated satisfactory MRI clarity versus cobalt-chromium or stainless steel discs§,4
Risks include wear debris.
Motion preserving implant
Range of motion with the Prestige LP™ cervical disc system
- Ball and trough articulation is designed to allow for a variable center of rotation (COR) that is located within an intended physiological area of the cervical spine
- Allows for a maximum of 10 degrees of lateral bending and flexion/extension from neutral, unlimited axial rotation and ± 2 mm AP translation
- Has no mobile core that could migrate from the device postoperatively
Risks include loss of motion.
Streamlined instruments
Surgical technique and fixation with the Prestige LP™ streamlined instrument set
- Predictable, reproducible implant positioning with cannulated drill and rail punch designed to allow trial to remain in disc space between steps to prevent collapse or loss of midline◊
- Low profile press-fit rails with anti-migration teeth for fixation
- Commercially pure titanium (CP Ti) plasma thermal sprayed coating designed to permit bony on-growth for additional device incorporation.
Ten-year clinical outcomes
A prospective, randomized, controlled, multicenter FDA-approved clinical trial assessed the ten-year clinical safety and effectiveness of cervical arthroplasty compared to anterior cervical discectomy and fusion (ACDF).2 The clinical trial involved 397 patients (209 patients who received the Prestige LP™ cervical disc at two adjacent levels and 188 patients who underwent a fusion procedure, ACDF, at two adjacent levels).
About Medtronic
A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives. Website: http://www.medtronic.com